Fudan University

This study is testing if a shorter, 4-month course of chemotherapy is as effective as the standard 6-month course for patients who have had surgery for stomach cancer. It involves over 1,000 patients and aims to see if the shorter treatment can prevent cancer from returning just …

This study is testing whether adding a new immunotherapy drug called cadonilimab (AK104) to standard chemotherapy and radiation can better control advanced, inoperable lung cancer. It involves 41 patients who will receive the drug before, during, and for a year after their standa…

This study aims to find out which of two standard chemotherapy regimens is more effective and safer for patients after breast cancer surgery. It involves 1,560 women with specific types of breast cancer that has spread to lymph nodes. Researchers are comparing two different drug …

This study is testing whether personalized drug treatments can help control advanced salivary gland cancer that has returned or spread. It will enroll 88 adults and assign them to one of four different drug regimens based on specific markers found in their tumor. The goal is to s…

This study looks back at medical records to see how well a combination treatment works for people with a specific type of advanced lung cancer that has spread to the brain and is causing symptoms. The treatment combines a targeted drug (osimertinib) with precise, focused radiatio…

This study is for people with a specific type of advanced lung cancer that has spread to the brain. After initial treatment with targeted drugs, if only a few small brain tumors remain, the trial tests whether adding a very precise form of radiation (stereotactic radiotherapy) ca…

This study is testing a new first treatment for early-stage MALT lymphoma, a type of slow-growing cancer. It combines a targeted drug (orelabrutinib) with a very low dose of radiation, aiming to control the disease effectively while minimizing side effects. The trial will enroll …

This study is testing whether adding the drug abemaciclib to standard chemotherapy can help control advanced colorectal cancer that has spread to the liver after other treatments have stopped working. It will involve about 16 patients at a single center in China to see if the com…

This study is testing a new method to detect stomach cancer early using a simple stool sample. Researchers will analyze DNA changes in the stool to see if they can accurately spot cancer and predict if it might come back after treatment. They are following 3000 people, including …

This study is testing whether two types of PET-CT scans can accurately predict if non-small cell lung cancer has spread to nearby lymph nodes before a patient has surgery. Researchers at Fudan University are enrolling 280 patients with early-stage lung cancer to compare the scan …

This study is testing whether drinking cola can help relieve sudden food blockages in the esophagus of people with esophageal cancer. Researchers are comparing cola to standard care in 50 patients to see if it improves the chance of relief within 24 hours. The goal is to find a s…

This study looked at patients with advanced breast cancer to understand if losing the estrogen receptor (ER) target during the disease is different from having triple-negative breast cancer from the beginning. Researchers compared survival and treatment response between these two…

This study aims to find out if analyzing tiny particles called exosomes from blood and lung fluid can predict how well advanced lung cancer patients will respond to standard treatments like immunotherapy or chemotherapy. Researchers will collect samples from 100 patients before a…

This study aims to figure out the best way to use a dengue vaccine in Yunnan Province, China. Researchers will use computer simulations to test different vaccination plans and see which one might prevent the most illness. The results will help local health officials make decision…